Maternally inherited diabetes and deafness complicated by mesangial galactose-deficient IgA1 deposits: a case report

被引:2
|
作者
Sugai, Keiji [1 ]
Ueda, Hiroyuki [1 ]
Morimoto, Keita [1 ]
Tanaka, Mai [1 ]
Takahashi, Daisuke [1 ]
Nakashima, Akio [1 ]
Kato, Junichiro [1 ]
Takahashi, Hiroshi [2 ]
Yamaguchi, Yutaka [3 ]
Kawamura, Tetsuya [1 ]
Hanaoka, Kazushige [1 ]
Miyazaki, Yoichi [1 ]
Yokoo, Takashi [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Tokyo, Japan
[2] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Tokyo, Japan
[3] Yamaguchis Pathol Lab, Chiba, Japan
来源
BMC NEPHROLOGY | 2018年 / 19卷
关键词
Maternally inherited diabetes and deafness; IgA deposits; Kidney disease; Case report; Galactose-deficient IgA1 variant; MITOCHONDRIAL TRNA(LEU(UUR)) GENE; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; TO-G MUTATION; O-GLYCOSYLATION; NEPHROPATHY; PROLIFERATION; DISAPPEARANCE; PREVALENCE; KIDNEYS; DONORS;
D O I
10.1186/s12882-018-1152-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundMaternally inherited diabetes and deafness (MIDD), a mitochondrial genetic disorder, typically affects the kidneys and results in end-stage renal disease. Early diagnosis of MIDD is challenging when renal manifestations precede other key clinical features such as diabetes and deafness and/or when the disease is complicated by other renal pathologies.Case presentationHere, we present the case of a 33-year-old Japanese woman who had initially been diagnosed with IgA nephropathy but was found to have MIDD 6years later. Two renal biopsies were conducted six years apart. While assessment of the first biopsy specimen with the monoclonal antibody (KM55) revealed mesangial IgA deposits (containing the galactose-deficient IgA1 variant [Gd-IgA1]), examination of the second specimen showed no mesangial IgA deposits and newly-developed glomerular global scleroses and tubular damage. Granular swollen epithelial cells (GSECs), characterised by abnormal mitochondria, were observed among the tubules and collecting ducts in both biopsy specimens. Mitochondrial DNA analysis revealed an m.3243A>G mutation.ConclusionsWe rediscovered the usefulness of GSECs as a pathologically distinctive feature of mitochondrial nephropathy and reviewed the literature regarding MIDD complicated by mesangial IgA deposition. Furthermore, we demonstrate that the mesangial IgA deposits in this patient consisted of the galactose-deficient IgA1 variant. The monoclonal antibody (KM55) might be a useful tool to distinguish IgAN from latent IgA deposits.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Clinical Significance of Serum Galactose-Deficient IgA1 Level in Children with IgA Nephropathy
    Irabu, Hitoshi
    Shimizu, Masaki
    Kaneko, Shuya
    Inoue, Natsumi
    Mizuta, Mao
    Ohta, Kazuhide
    Yachie, Akihiro
    JOURNAL OF IMMUNOLOGY RESEARCH, 2020, 2020
  • [32] Cellular Signaling and Production of Galactose-Deficient IgA1 in IgA Nephropathy, an Autoimmune Disease
    Reily, Colin
    Ueda, Hiroyuki
    Huang, Zhi-Qiang
    Mestecky, Jiri
    Julian, Bruce A.
    Willey, Christopher D.
    Novak, Jan
    JOURNAL OF IMMUNOLOGY RESEARCH, 2014, 2014
  • [33] Galactose-Deficient IgA1 in African Americans with IgA Nephropathy: Serum Levels and Heritability
    Hastings, M. Colleen
    Moldoveanu, Zina
    Julian, Bruce A.
    Novak, Jan
    Sanders, John T.
    McGlothan, Kim R.
    Gharavi, Ali G.
    Wyatt, Robert J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (11): : 2069 - 2074
  • [34] Somatic Mutations Modulate Autoantibodies against Galactose-Deficient IgA1 in IgA Nephropathy
    Huang, Zhi Qiang
    Raska, Milan
    Stewart, Tyler J.
    Reily, Colin
    King, R. Glenn
    Crossman, David K.
    Crowley, Michael R.
    Hargett, Audra
    Zhang, Zhixin
    Suzuki, Hitoshi
    Hall, Stacy
    Wyatt, Robert J.
    Julian, Bruce A.
    Renfrow, Matthew B.
    Gharavi, Ali G.
    Novak, Jan
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (11): : 3278 - 3284
  • [35] Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
    Moldoveanu, Z.
    Wyatt, R. J.
    Lee, J. Y.
    Tomana, M.
    Julian, B. A.
    Mestecky, J.
    Huang, W-Q
    Anreddy, S. R.
    Hall, S.
    Hastings, M. C.
    Lau, K. K.
    Cook, W. J.
    Novak, J.
    KIDNEY INTERNATIONAL, 2007, 71 (11) : 1148 - 1154
  • [36] Serum Galactose-Deficient IgA1 Level Is Not Associated with Proteinuria in Children with IgA Nephropathy
    Hastings, M. Colleen
    Afshan, Sabahat
    Sanders, John T.
    Kane, Oulimata
    Eison, T. Matthew
    Lau, Keith K.
    Moldoveanu, Zina
    Julian, Bruce A.
    Novak, Jan
    Wyatt, Robert J.
    INTERNATIONAL JOURNAL OF NEPHROLOGY, 2012, 2012
  • [37] The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
    Zhao, Na
    Hou, Ping
    Lv, Jicheng
    Moldoveanu, Zina
    Li, Yifu
    Kiryluk, Krzysztof
    Gharavi, Ali G.
    Novak, Jan
    Zhang, Hong
    KIDNEY INTERNATIONAL, 2012, 82 (07) : 790 - 796
  • [38] Plasma galactose-deficient IgA1 and C3 and CKD Progression in IgA nephropathy
    Yu, G. -Z.
    Chen, P.
    Zhang, X.
    Shi, S. -F.
    Lv, J. -C.
    Zhang, H.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 916 - 916
  • [39] Plasma Galactose-Deficient IgA1 and C3 and CKD Progression in IgA Nephropathy
    Chen, Pei
    Yu, Guizhen
    Zhang, Xue
    Xie, Xinfang
    Wang, Jinwei
    Shi, Sufang
    Liu, Lijun
    Lv, Jicheng
    Zhang, Hong
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (10): : 1458 - 1465
  • [40] Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy
    Yamada, Koshi
    Huang, Zhi Qiang
    Raska, Milan
    Reily, Colin
    Anderson, Joshua C.
    Suzukia, Hitoshi
    Kiryluk, Krzysztof
    Gharavi, Ali G.
    Julian, Bruce A.
    Willey, Christopher D.
    Novak, Jan
    KIDNEY DISEASES, 2020, 6 (03) : 168 - 180